Disseminated granuloma annulare: A cutaneous adverse effect of anti-TNF agents
Tumor necrosis factor-alpha (TNF-α) inhibitors, such as etanercept, infliximab, and adalimumab, bind to TNF-α and thereby act as anti-inflammatory agents. This group of drugs has been approved for the treatment of rheumatoid arthritis, psoriatic arthritis, moderate to severe plaque psoriasis, ankylo...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2011-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_e87ff3c7744b45e89f1bb49aff23c4a9 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Mondhipa Ratnarathorn |e author |
| 700 | 1 | 0 | |a Siba P Raychaudhuri |e author |
| 700 | 1 | 0 | |a Stanley Naguwa |e author |
| 245 | 0 | 0 | |a Disseminated granuloma annulare: A cutaneous adverse effect of anti-TNF agents |
| 260 | |b Wolters Kluwer Medknow Publications, |c 2011-01-01T00:00:00Z. | ||
| 500 | |a 0019-5154 | ||
| 500 | |a 1998-3611 | ||
| 500 | |a 10.4103/0019-5154.91847 | ||
| 520 | |a Tumor necrosis factor-alpha (TNF-α) inhibitors, such as etanercept, infliximab, and adalimumab, bind to TNF-α and thereby act as anti-inflammatory agents. This group of drugs has been approved for the treatment of rheumatoid arthritis, psoriatic arthritis, moderate to severe plaque psoriasis, ankylosing spodylitis, Crohn disease, and juvenile idiopathic arthritis. We describe a 56-year-old woman who developed an erythematous pruritic rash on both arms-diagnosed as granuloma annulare by skin biopsy-approximately 22 months after initiating adalimumab for treatment of rheumatoid arthritis. On stopping adalimumab there was total clearance of the skin lesions, but a similar rash developed again when her treatment was switched to another anti-TNF agent (etanercept). This clinical observation supports a link between TNF inhibition and the development of granuloma annulare. | ||
| 546 | |a EN | ||
| 690 | |a Adverse effect | ||
| 690 | |a anti-TNF therapy | ||
| 690 | |a granuloma annulare | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Indian Journal of Dermatology, Vol 56, Iss 6, Pp 752-754 (2011) | |
| 787 | 0 | |n http://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=6;spage=752;epage=754;aulast=Ratnarathorn | |
| 787 | 0 | |n https://doaj.org/toc/0019-5154 | |
| 787 | 0 | |n https://doaj.org/toc/1998-3611 | |
| 856 | 4 | 1 | |u https://doaj.org/article/e87ff3c7744b45e89f1bb49aff23c4a9 |z Connect to this object online. |